Overview of HBV associated (Mutation)

ID Literature Title Group
1 16637866 Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection
Mutation
2 30505167 Hepatitis B virus precore G1896A mutation in chronic liver disease patients with HBeAg negative serology from North India
Mutation
3 10535488 Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen
Mutation
4 11002246 Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma
Mutation
5 14756274 Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation
Mutation
6 16080797 HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers
Mutation
7 17888035 Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma
Mutation
8 21461076 Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection
Mutation
9 21490166 Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection
Mutation
10 21933446 Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
Mutation
11 22882650 Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients
Mutation
12 23383661 Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma
Mutation
13 32568442 The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population
Mutation
14 34899733 The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
Mutation
15 37735836 CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes
Mutation
16 12436473 Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies
Mutation
17 17030194 Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient
Mutation
18 22342116 Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy
Mutation
19 26577140 Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection
Mutation
20 34920100 Novel X gene point mutations in chronic hepatitis B and HBV related cirrhotic patients
Mutation
21 16618410 High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases
Mutation
22 17203204 Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam
Mutation
23 18551606 Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection
Mutation
24 29285238 Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients
Mutation
25 31565220 Association between host TNF-alpha, TGF-beta1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients
Mutation
26 35415256 Precore/core mutations of hepatitis B virus genotype D arising in different states of infection
Mutation
27 18844615 HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study
Mutation
28 20959817 Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma
Mutation
29 22919746 [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum]
Mutation
30 23272650 Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
Mutation
31 24637457 Mutation profiling of the hepatitis B virus strains circulating in North Indian population
Mutation
32 30043328 Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant
Mutation
33 31341154 Association Between HBx Variations and Development of Severe Liver Disease Among Indonesian Patients
Mutation
34 32523313 Conservation and variability of hepatitis B core at different chronic hepatitis stages
Mutation
35 33296295 Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
Mutation
36 34029727 Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression
Mutation
37 35880842 The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma
Mutation
38 38037048 HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population
Mutation
39 18508941 Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus
Mutation
40 20419326 Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma
Mutation
41 21323729 Natural history of chronic hepatitis B REVEALed
Mutation
42 21941645 Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia
Mutation
43 22720023 Hepatitis B virus gene mutations in liver diseases: a report from New Delhi
Mutation
44 23304671 HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China
Mutation
45 23903686 Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively
Mutation
46 25281206 Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma
Mutation
47 26290395 Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study
Mutation
48 26899956 Molecular characterization of hepatitis B virus from chronically-infected patients in Niamey, Niger
Mutation
49 28373061 Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer
Mutation
50 28654219 A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma
Mutation
51 28902288 Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases
Mutation
52 31105017 Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients
Mutation
53 32155009 [The prevalence clinically significant virus mutations among patients with chronic viral hepatitis B.]
Mutation
54 33947693 The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Mutation
55 31189581 Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing
Mutation
56 31846615 The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infection
Mutation
57 19817965 Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis
Mutation
58 26457811 Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection
Mutation
59 20675695 Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population
Mutation
60 27031988 Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans
Mutation
61 28236303 Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China
Mutation
62 28971485 Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients
Mutation
63 31153830 Occult HBV infection in patients with autoimmune hepatitis: A virological and clinical study
Mutation
64 19431214 A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan
Mutation
65 29434654 Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection
Mutation
66 24715933 Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran
Mutation
67 9687422 The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA
Mutation
68 15661154 Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion
Mutation
69 21331286 Expression of Hepatitis B Virus Surface Antigen Containing Y100C Variant Frequently Detected in Occult HBV Infection
Mutation
70 21358805 Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically
Mutation
71 21368417 Identification of recombinant intermediates of hepatitis B virus between genotype B and C in vitro
Mutation
72 21438026 Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival
Mutation
73 21704589 Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21
Mutation
74 21786803 Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion
Mutation
75 21860069 The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations
Mutation
76 21871497 The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
Mutation
77 21998953 [The cloning, expression, purification and immunological identification of wild-type and mutant hepatitis B virus X gene in pGEX-6P-2 system]
Mutation
78 22082274 Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene
Mutation
79 22100339 The effect of the G1888A mutation of subgenotype A1 of hepatitis B virus on the translation of the core protein
Mutation
80 22170538 Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen
Mutation
81 22296790 Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples
Mutation
82 22314422 Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants
Mutation
83 22505793 Hepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spots
Mutation
84 22595307 The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays
Mutation
85 22668794 In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations
Mutation
86 23237841 2'-Fluoro-6'-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: in vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action
Mutation
87 23261845 The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir
Mutation
88 23301549 Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains
Mutation
89 23403838 A novel method for the analysis of drug-resistant phenotypes of hepatitis B virus
Mutation
90 26119876 Hepatitis B "e" antigen-mediated inhibition of HBV replication fitness and transcription efficiency in vitro
Mutation
91 26136564 An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation
Mutation
92 26201776 Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype
Mutation
93 26220282 Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro
Mutation
94 26322642 Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
Mutation
95 26336997 Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance
Mutation
96 26349829 A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation
Mutation
97 26541316 New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen
Mutation
98 26567840 Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis
Mutation
99 27132039 Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status
Mutation
100 27144395 Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon alpha
Mutation
101 27420729 HBx mutations promote hepatoma cell migration through the Wnt/beta-catenin signaling pathway
Mutation
102 27473751 Enhanced pregenomic RNA levels and lowered precore mRNA transcription efficiency in a genotype A hepatitis B virus genome with C1766T and T1768A mutations obtained from a fulminant hepatitis patient
Mutation
103 27588233 Compensatory variances of drug-induced hepatitis B virus YMDD mutations
Mutation
104 27642350 Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis
Mutation
105 27694733 Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China
Mutation
106 27871021 Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis
Mutation
107 27878103 Role of RNA secondary structure in emergence of compartment specific hepatitis B virus immune escape variants
Mutation
108 27976732 Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems
Mutation
109 28045894 Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity
Mutation
110 28205569 Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms
Mutation
111 28260621 Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region
Mutation
112 28322895 Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs
Mutation
113 29669831 Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation
Mutation
114 30089690 Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals
Mutation
115 30179704 Amino acid substitutions Q129N and T131N/M133T in hepatitis B surface antigen (HBsAg) interfere with the immunogenicity of the corresponding HBsAg or viral replication ability
Mutation
116 30202825 Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis
Mutation
117 30358169 14-3-3zeta binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells
Mutation
118 30771531 Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy
Mutation
119 30902704 Naturally occurring core protein mutations compensate for the reduced replication fitness of a lamivudine-resistant HBV isolate
Mutation
120 30943997 Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors
Mutation
121 31218588 Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs
Mutation
122 31706164 Residues Asn118 and Glu119 of hepatitis B virus X protein are critical for HBx-mediated inhibition of RIG-I-MAVS signaling
Mutation
123 32084506 7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety
Mutation
124 32104912 The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape
Mutation
125 32283837 In silico Analysis of Genetic Diversity of Human Hepatitis B Virus in Southeast Asia, Australia and New Zealand
Mutation
126 32542478 Analysis of HBsAg mutations in the 25 years after the implementation of the hepatitis B vaccination plan in China
Mutation
127 32702076 Protein phosphatase 1 catalyzes HBV core protein dephosphorylation and is co-packaged with viral pregenomic RNA into nucleocapsids
Mutation
128 32760388 Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants
Mutation
129 32790777 A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants
Mutation
130 32868329 Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731
Mutation
131 32882910 Expression Level of Small Envelope Protein in Addition to Sequence Divergence inside Its Major Hydrophilic Region Contributes to More Efficient Surface Antigen Secretion by Hepatitis B Virus Subgenotype D2 than Subgenotype A2
Mutation
132 32887289 Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi
Mutation
133 33079954 Biogenesis and molecular characteristics of serum hepatitis B virus RNA
Mutation
134 33238650 Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
Mutation
135 33493210 Multiple roles of PP2A binding motif in hepatitis B virus core linker and PP2A in regulating core phosphorylation state and viral replication
Mutation
136 33652602 Phosphorylation of Phylogenetically Conserved Amino Acid Residues Confines HBx within Different Cell Compartments of Human Hepatocarcinoma Cells
Mutation
137 33803998 rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome
Mutation
138 33879615 A pocket-factor-triggered conformational switch in the hepatitis B virus capsid
Mutation
139 33893696 Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Mutation
140 33903819 Entecavir resistance in a patient with treatment-naive HBV: A case report
Mutation
141 34406663 Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations
Mutation
142 34920663 Signal-On Electrochemical Detection for Drug-Resistant Hepatitis B Virus Mutants through Three-Way Junction Transduction and Exonuclease III-Assisted Catalyzed Hairpin Assembly
Mutation
143 35214692 Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro
Mutation
144 19800842 Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study
Mutation
145 26390290 Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
Mutation
146 27354181 HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia
Mutation
147 12368144 [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]
Mutation
148 20080060 Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B
Mutation
149 24021712 Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions
Mutation
150 23852705 A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations
Mutation
151 23871771 Positive selection signals of hepatitis B virus and their association with disease stages and viral genotypes
Mutation
152 27328656 Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories
Mutation
153 20070500 Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis
Mutation
154 20848146 Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure
Mutation
155 21739444 Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure
Mutation
156 26202756 Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China
Mutation
157 9303514 Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis
Mutation
158 10745228 Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis
Mutation
159 18428142 Analysis of the entire nucleotide sequence of hepatitis B causing consecutive cases of fatal fulminant hepatitis in Miyagi Prefecture Japan
Mutation
160 9425945 Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
Mutation
161 23805180 Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma
Mutation
162 35809696 Identification of a novel variant of hepatitis B virus isolated from patient co-infected with hepatitis C virus
Mutation
163 12210410 Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection
Mutation
164 19574418 Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis
Mutation
165 19664630 Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression
Mutation
166 19998495 Clinical relevance and public health significance of hepatitis B virus genomic variations
Mutation
167 20160279 Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study
Mutation
168 21104161 Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma
Mutation
169 22014121 Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
Mutation
170 24973814 Mother-to-child transmission of hepatitis B virus: evolution of hepatocellular carcinoma-related viral mutations in the post-immunization era
Mutation
171 30702819 Analyses of the Genetic Diversities and Mutations of the Hepatitis B Virus Genome BCP/Pre C Region
Mutation
172 34534105 Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
Mutation
173 30406036 The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease
Mutation
174 31501793 Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals
Mutation
175 22313146 Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.